Posttraumatic stress disorder (
PTSD) is a severe
trauma and stress-related disorder associated with different somatic comorbidities, especially cardiovascular and metabolic disorders, and with chronic low-grade
inflammation. Altered balance of the hypothalamic-pituitary-adrenal (HPA) axis,
cytokines and
chemokines, C-reactive
protein, oxidative stress markers,
kynurenine pathways, and gut microbiota might be involved in the alterations of certain brain regions regulating fear conditioning and memory processes, that are all altered in
PTSD. In addition to the HPA axis, the gut microbiota maintains the balance and interaction of the immune, CNS, and endocrine pathways forming the gut-brain axis. Disbalance in the HPA axis, gut-brain axis, oxidative stress pathways and
kynurenine pathways, altered immune signaling and disrupted homeostasis, as well as the association of the
PTSD with the
inflammation and disrupted cognition support the search for novel strategies for treatment of
PTSD. Besides potential anti-inflammatory treatment, dietary interventions or the use of beneficial bacteria, such as probiotics, can potentially improve the composition and the function of the bacterial community in the gut. Therefore, bacterial supplements and controlled dietary changes, with exercise, might have beneficial effects on the psychological and cognitive functions in patients with
PTSD. These new treatments should be aimed to attenuate inflammatory processes and consequently to reduce
PTSD symptoms but also to improve cognition and reduce cardio-metabolic disorders associated so frequently with
PTSD.